Monday - April 29, 2024
Institute for Policy Innovation Opposes IPI: Problems With a Prescription Drug Pricing Index
July 25, 2020
DALLAS, Texas, July 25 -- The Institute for Policy Innovation issued the following news release:

The Institute for Policy Innovation (IPI), a 33 year-old free market public policy research organization, released this statement in opposition to the Trump administration's International Pricing Indexing (IPI) plan for prescription drugs:

President Donald Trump reportedly plans to sign an executive order setting up an International Pricing Index for certain prescription dr . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products